Published in Clin Gastroenterol on May 01, 1976
Immunodiagnosis of alpha chain disease. Clin Exp Immunol (1979) 1.05
Characterization of the IgA immunocyte population and its product in a patient with excessive intestinal formation of IgA. Clin Exp Immunol (1977) 0.90
Alpha heavy chain disease (report of 18 cases from Iraq). Gut (1978) 0.88
Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases. Clin Exp Immunol (1979) 0.78
Gamma heavy chain disease simulating alpha chain disease. Gut (1978) 0.77
Alpha heavy chain disease developing in an Asian resident in the United Kingdom and responding to antibiotics. Postgrad Med J (1983) 0.75
Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med (1974) 6.77
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15
Alpha-chain disease: a new immunoglobulin abnormality. Science (1968) 3.09
Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood (1972) 2.91
Antibodies to native and denatured deoxyribonucleic acid in systemic lupus erythematosus. J Clin Invest (1967) 2.51
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome. N Engl J Med (1973) 2.32
Alpha chain disease. Ann N Y Acad Sci (1971) 2.31
Antibody activity of human myeloma globulins. Semin Hematol (1973) 2.20
Immunoglobulins on the surface of lymphoid cells in Waldenström's macroglobulinemia. J Clin Invest (1972) 2.15
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14
Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci (1991) 2.11
B-cell neoplasia in man. Lancet (1974) 2.11
[Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases]. Presse Med (1967) 2.10
Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology (1999) 2.01
Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest (1985) 2.00
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet (2001) 1.97
[Membrane monoclonal immunoglobulins in chronic lymphoid leukemia]. Rev Eur Etud Clin Biol (1971) 1.91
Immunochemical studies in four cases of alpha chain disease. J Clin Invest (1969) 1.90
Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia. J Clin Invest (1970) 1.86
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Anti-human immunoglobulin G activity of membrane-bound monoclonal immunoglobulin M in lymphoproliferative disorders. Proc Natl Acad Sci U S A (1972) 1.81
Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69
Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci (1989) 1.63
Editorial: B-cell and T-cell markers in lymphoid proliferations. N Engl J Med (1974) 1.63
Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet (1975) 1.62
Unreleased intracellular monoclonal macroglobulin in chronic lymphocytic leukaemia. Clin Exp Immunol (1972) 1.57
Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease"). Digestion (1968) 1.56
Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol (1987) 1.56
Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia. Blood (1993) 1.55
Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut (1997) 1.55
Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr (1992) 1.54
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
CD4+ lymphocytopenia without HIV in patient with cryptococcal disease. Lancet (1991) 1.52
Association of hepatic vein obstruction and coeliac disease in North African subjects. J Hepatol (1994) 1.51
Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study. Eur J Gastroenterol Hepatol (2001) 1.46
Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases. Clin Immunol Immunopathol (1973) 1.46
Studies on antinuclear antibodies. Ann N Y Acad Sci (1965) 1.45
Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest (1984) 1.44
[Treatment of Crohn's disease with azathioprine or 6-mercaptopurine. Retrospective study of 126 cases]. Gastroenterol Clin Biol (1990) 1.44
IgG myeloma cryoglobulin with antistreptolysin activity. Nature (1968) 1.43
Do patients with short-bowel syndrome need a lactose-free diet? Nutrition (1997) 1.43
Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev (1993) 1.42
CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet (1992) 1.42
B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transplant Rev (1973) 1.41
Generation of immunoglobulin class diversity in b cells: a discussion with emphasis on idg development. Ann Immunol (Paris) (1976) 1.40
Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39
The method of intraluminal perfusion of the human small intestine. I. Principle and technique. Digestion (1973) 1.37
Heavy chain diseases: current findings and concepts. Immunol Rev (1979) 1.35
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet (1999) 1.35
Papain digestion fragments of human IgM globulins. J Exp Med (1968) 1.34
Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci (1994) 1.31
Alpha-chain disease. Pathogenesis and relation to Mediterranean lymphoma. Lancet (1973) 1.31
Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr (1997) 1.31
Intracellular "monoclonal" immunoglobulin in non-secretory human myeloma. J Immunol (1970) 1.30
Possible induction of antinuclear antibodies by isoniazid. Lancet (1966) 1.29
The immunological classification of acute lymphoblastic leukemias. Cancer (1978) 1.29
Classification of primary immunodeficiencies. N Engl J Med (1973) 1.28
Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol (1999) 1.28
Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg (1997) 1.28
Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans. Gastroenterology (1993) 1.26
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr (1999) 1.26
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Immunochemical, clical, and pathological features of alpha-chain disease. Arch Intern Med (1975) 1.25
The inhibition by normal gamma-G-globulins of antibodies specific for individual gamma-G-myeloma proteins. J Immunol (1968) 1.25
[The "paraproteins" of types Ig G and Ig A in subjects without Kahler's disease]. Rev Fr Etud Clin Biol (1967) 1.24
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology (1992) 1.24
Pathological study of alpha-chain disease, with special emphasis on evolution. Cancer (1977) 1.23
Immunoglobulin abnormalities in families of patients with Waldenström's macroglobulinemia. Am J Med (1967) 1.22
Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology (1999) 1.22
Motor activity recorded in the unprepared colon of healthy humans. Gut (1995) 1.21
Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol (1987) 1.20
IgD and IgM on the membrane of lymphoid cells in macroglobulinemia. Evidence for identity of membrane IgD and IgM antibody activity in a case with anti-IgG receptors. Eur J Immunol (1974) 1.20
Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs. Gastroenterology (1997) 1.20
Idiotype-bearing and antigen-binding receptors produced by blood T lymphocytes in a case of human myeloma. Eur J Immunol (1977) 1.19
Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients. Br J Haematol (1976) 1.19
Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett (1992) 1.18
Colonic metabolism of wheat starch in healthy humans. Effects on fecal outputs and clinical symptoms. Gastroenterology (1986) 1.18
Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med (1987) 1.16
Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Am J Med (1980) 1.15
Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. Br J Nutr (1990) 1.15
Serum monoclonal immunoglobulins in childhood. Arch Dis Child (1973) 1.14
Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin Exp Immunol (1968) 1.12
Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer (1981) 1.11
Waldenström's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood (1983) 1.11
Surface immunoglobulins on human lymphoid cells. Prog Clin Immunol (1974) 1.10
Hairy-cell leukaemia with polyarteritis nodosa. Lancet (1979) 1.09
Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology (1991) 1.09
Acute lymphoblastic leukemia with pre-B-cell characteristics. Blood (1979) 1.09
Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology (1993) 1.08
Ultrastructure of papain and pepsin digestion fragments of human IgM globulins. J Exp Med (1969) 1.08
Transient human monoclonal immunoglobulins. Scand J Immunol (1972) 1.08
[Clinical, anatomo-pathological and immunochemical study of a further case of alpha chain disease followed for 5 years]. Rev Eur Etud Clin Biol (1972) 1.08